Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Mid-range Performer
1101.0000 -5.30 (-0.48%)
NSE Oct 17, 2025 15:31 PM
Volume: 938.1K
 

logo
Aurobindo Pharma Ltd.
06 Jun 2016
1101.00
-0.48%
Economic Times
The company paid its CEO, M Govindarajan, an average annual compensation of Rs 9.5 crore, which is above the average CEO salary during the period.
Promoters pledged 0.42% of shares in last quarter. Total pledge stands at 17.50% of promoter holdings
Aurobindo Pharma gets best value from payout to CEO in 3 years
Economic Times | 06 Jun 2016
More from Aurobindo Pharma Ltd.
Recommended
Five Interesting Stocks Today - October 17, 2025
The Baseline | 17 Oct 2025, 04:53PM
Market closes higher, RARE Enterprises buys 0.9% stake in Federal Bank in Q2
Trendlyne Marketwatch | 17 Oct 2025, 04:18PM
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
| 15 Jul 2020